Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about IPSEY
Recent news which mentions IPSEY
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
June 11, 2024
Tickers
GNFT
IPSEF
IPSEY
NEWS
Tags
Stories That Matter
GNFT
News
From
Benzinga
3 Promising Biotech Stocks Flying Under the Radar
November 08, 2023
Tickers
ABOS
BMRN
EXEL
HALO
Tags
EXEL
Market News
Stocks to Buy
From
InvestorPlace
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
Tickers
EXEL
IPSEF
IPSEY
RHHBF
Tags
General
RHHBY
News
From
Benzinga
Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
June 30, 2023
Tickers
CBAY
GNFT
IPSEY
Tags
Briefs
News
Movers
From
Benzinga
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
June 30, 2023
Tickers
GNFT
IPSEY
Tags
Benzinga
Penny Stocks
GNFT
From
Benzinga
What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
May 22, 2023
Tickers
CBAY
DRRX
GNFT
ICPT
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
Tickers
ALBO
AZN
CINC
IPSEY
Tags
Recent Press Releases
IPSEY
ALBO
From
Motley Fool
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
January 09, 2023
Tickers
ALBO
DCT
IPSEY
Tags
Market News
ALBO
IPSEY
From
Motley Fool
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
January 09, 2023
Tickers
ALBO
IPSEF
IPSEY
Tags
Market News
IPSEF
Trading Ideas
From
Benzinga
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
December 09, 2022
Tickers
EXEL
IPSEY
RHHBY
TAK
Tags
Briefs
News
Biotech
From
Benzinga
Why Merrimack Shares Are Surging Over 200% Today?
November 09, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Benzinga
MACK
Trading Ideas
From
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
Tickers
APLS
ARDX
AZN
FOLD
Tags
News
SCYX
PRVB
From
Benzinga
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
AZN
Benzinga
Penny Stocks
From
Benzinga
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
September 19, 2022
Tickers
GNFT
IPSEY
Tags
General
M&A
Briefs
From
Benzinga
Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure
August 03, 2022
Tickers
IPSEF
IPSEY
MACK
Tags
Benzinga
IPSEF
Trading Ideas
From
Benzinga
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
June 28, 2022
Tickers
AFIB
AGRX
AGTC
AMST
Tags
Market News
SRRK
STSA
From
Benzinga
Why Adaptimmune Therapeutics Stock Is Popping Today
June 27, 2022
Tickers
ADAP
EPZM
IPSEY
Tags
Market News
EPZM
IPSEY
From
Motley Fool
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
June 27, 2022
Tickers
AFIB
AGRX
AGTC
ARMP
Tags
TNXP
BLPH
SSRM
From
Benzinga
Why Epizyme Stock Is Soaring Today
June 27, 2022
Tickers
EPZM
IPSEY
Tags
Market News
Recent Press Releases
EPZM
From
Motley Fool
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Tickers
ALPMF
ALPMY
AXSM
AZN
Tags
M&A
General
AXSM
From
Benzinga
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
June 27, 2022
Tickers
EPZM
IPSEF
IPSEY
Tags
Movers
why it's moving
News
From
Benzinga
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers
BMY
ETSY
EXEL
IPSEY
Tags
Market News
EXEL
ETSY
From
Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers
ACAD
AQST
BIIB
BLTE
Tags
BIIB
INFI
ESPR
From
Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
Market News
EXEL
Benzinga
From
Benzinga
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers
EXEL
IPSEF
IPSEY
Tags
Biotech
Health Care
IPSEY
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Market News
Liver Cancer
Benzinga
From
Benzinga
A Peek Into The Markets: US Stock Futures Down Following Friday's Plunge
January 24, 2022
Tickers
ABBV
GILD
HAL
IBM
Tags
OPK
GILD
Market News
From
Benzinga
Ipsen's Sohonos Scores Canadian Approval For Rare Connective Tissue Disease
January 24, 2022
Tickers
IPSEF
IPSEY
Tags
IPSEY
Health Care
General
From
Benzinga
GNFT Stock Alert: 15 Things to Know About Biotech Penny Stock Genfit as Shares Go Gangbusters
December 17, 2021
Tickers
BABA
FUTU
GNFT
IPSEY
Tags
FUTU
IPSEY
NASDAQ:GNFT,OTCMKTS:IPSEY,NYSE:BABA,NASDAQ:NVAX,NASDAQ:FUTU
From
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 17, 2021
Tickers
ABEO
ADGI
BLIN
CERN
Tags
RIVN
TIGR
IMMX
From
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.